✅ ANSWER KEY — all fields pre-filled. Use this to check your work.

GI Lecture 19–20: Intestinal Pathology — Answer Key

Built from GI Lecture 19–20 (LOs 1–8). Close notes. Fill from memory. Reveal only after a genuine attempt.

📖 Use alongside: GI Lecture 19–20 — Intestinal Pathology (HoyaDocs) Focus on: Meckel's rule of 2's, obstruction mechanisms, IBD (Crohn vs UC), celiac serology, ischemic bowel, diverticular disease, colonic polyps, and colorectal cancer sequencing.
Congenital & Diverticula
Obstruction & Hernias
Ischemic Bowel & Malabsorption
Celiac & IBD Overview
IBD Deep Dive & Diverticulitis
Polyps & Colorectal Cancer
Practice Qs
LO 1
ON EXAM — Meckel's rule of 2's, true vs pseudo diverticula, ectopic tissue complications, Hirschsprung RET mutations
Diverticula classification (LO1)
FeatureTrue DiverticulumPseudo (False) Diverticulum
Wall layers
All 3 (mucosa + submucosa + muscularis)
Mucosa + submucosa only
Origin
Congenital (developmental failure)
Acquired (increased intraluminal pressure)
Example
Meckel diverticulum
Colonic diverticulosis
Can contain ectopic tissue?
Yes
No
Meckel diverticulum — rule of 2's (LO1)
EXAM CLASSIC: Everything about Meckel comes in 2's — memorize this mnemonic cold.
Population & Size
2%
2 inches
2 feet
Ectopic Tissue & Presentation
2
Gastric mucosa and pancreatic tissue
2 (or before age 2)
Embryology
Vitelline duct (omphalomesenteric duct)
Week 7
Ectopic gastric mucosa
Meckel diverticulum complications (LO1)
ComplicationMechanism / Key FeatureMost Common in Which Age?
GI bleeding
Ectopic gastric mucosa secretes acid → ulcerates adjacent ileal mucosa → painless bleeding
Children <2 years
Obstruction
Diverticulum acts as lead point for volvulus, intussusception, or adhesion
Any age
Volvulus
Intestines wrap around the diverticulum → twisting obstruction
Adults
Diverticulitis
Inflammation of the diverticulum → RLQ pain (mimics appendicitis)
Any age
Hirschsprung disease — pathogenesis & diagnosis (LO1)
Neural crest cells fail to migrate into distal colon
RET gene (proto-oncogene)
Ganglion cells (enteric neurons)
Ganglion cells in myenteric and submucosal plexuses (aganglionosis)
Hypertrophic nerve trunks with increased acetylcholinesterase staining
Newborn fails to pass meconium within first 48 hours
Usually rectosigmoid junction; can extend more proximally (long-segment disease)
10–20 fold increased risk
LO 2
ON EXAM — Types of hernia, strangulation vs simple obstruction, adhesions, volvulus, intussusception lead points, imaging clues
Hernia classification & anatomy (LO2)
Hernia TypeAnatomic LocationRisk Factors / PathogenesisStrangulation Risk?
Hiatal hernia
Esophageal hiatus of diaphragm
Increased intra-abdominal pressure, age-related muscle laxity, smoking, obesity
No
Umbilical hernia
Umbilical ring (congenital weakness)
Patent umbilical opening, increased abdominal pressure
Rare
Ventral/incisional
Surgical incision site
Post-surgical, obesity, wound infection, poor healing
Moderate
Inguinal hernia
Inguinal canal (above inguinal ligament)
Congenital weakness (patent processus vaginalis) or acquired (straining, heavy lifting)
High (~10%)
Femoral hernia
Femoral ring (below inguinal ligament, medial to femoral vessels)
Femoral ring weakness; rare; females >> males
HIGHEST (~20%)
Obstruction types — mechanisms (LO2)
KEY: Simple obstruction = reduced lumen. Strangulation = compromised blood supply. Strangulation is surgical emergency (necrosis within 6–8 hrs).
Obstruction TypeMechanismLeads to Strangulation?Surgical Emergency?
Adhesions (most common)
Fibrous bands from previous surgery, peritonitis bind bowel
No (low risk)
No (managed conservatively)
Volvulus
Bowel twists on mesentery → lumen obstructed + blood supply compromised
Yes (high risk)
Yes
Intussusception
Proximal bowel segment invaginates into distal segment
Yes (if not reduced promptly)
Yes (if >24–48 hrs or failed reduction)
Hernia (incarcerated)
Hernia contents trapped in defect → lumen narrowed
Yes (depends on neck width)
Yes (risk of strangulation)
Comparison of obstruction presentations (LO2)
FeatureAdhesionsVolvulusIntussusception
Most common location
Small bowel (jejunum/ileum)
Sigmoid colon (most common)
Ileocolic junction
Classic imaging finding
Transition point; no distinctive sign
Bird's beak sign (twisted mesentery)
Target or doughnut sign
Age of presentation
Any age (post-surgery)
Sigmoid: elderly; cecal: adults
6 months–3 years (peak 1–2 yrs)
Bloody stool ("current jelly")?
No
Late finding if necrosis
Yes (classic)
Volvulus pathophysiology (LO2)
Institutionalized elderly (mean age ~65); cognitive impairment, immobility, chronic constipation, neuropsychiatric drugs
More mobile cecal wall; twists on mesentery; higher perforation risk; less responsive to non-operative reduction
Twisted mesentery at the point of torsion (rectosigmoid junction in sigmoid volvulus)
Hydrostatic pressure straightens the twist; resolves obstruction in ~70% without surgery
Sigmoid enema decompression successful in most; cecal volvulus less amenable to non-operative reduction; higher risk of perforation
Intussusception clinical pearls (LO2)
6 months to 3 years (peak 1–2 years)
Malignancy (lymphoma, adenocarcinoma), Meckel diverticulum, polyp
Colicky pain + palpable abdominal mass + currant jelly stools (blood-stained)
Cross-section of invaginated mesentery with blood vessels surrounded by bowel wall
Air enema or barium enema (70% success); contraindicated if perforation, peritonitis, or >24–48 hrs symptoms
LO 3 · LO 4
ON EXAM — Watershed zones, SMA embolism pain out of proportion, acute vs chronic ischemia, malabsorption causes, fat-soluble vitamin deficiency pattern
Ischemic bowel disease — arterial territories (LO3)
ArteryEmbryologic OriginStructures SuppliedWatershed Zone Vulnerability
Celiac
Foregut
Distal esophagus, stomach, duodenum (proximal 2 parts), liver, gallbladder, spleen, pancreatic head
None (sole supply)
SMA (Midgut)
Midgut
Duodenum (distal 3rd & 4th), jejunum, ileum, cecum, ascending colon, proximal 2/3 transverse colon
Splenic flexure (SMA/IMA border) — MOST VULNERABLE
IMA (Hindgut)
Hindgut
Distal 1/3 transverse colon, descending colon, sigmoid, upper rectum
Rectosigmoid junction (IMA/pudendal border) — second vulnerable
Acute mesenteric ischemia — types & clues (LO3)
CLASSIC STEP 1 CLUE: Severe periumbilical pain OUT OF PROPORTION to soft abdominal exam. This is the pathognomonic presentation before peritoneal signs develop.
TypeCauseVascular PathologyRisk Factors
Arterial embolism (most common)
SMA occlusion by thrombus from heart
Embolic obstruction; sudden onset
Atrial fibrillation, cardiac thrombus, endocarditis
Arterial thrombosis
SMA occlusion at site of atherosclerotic lesion
Stenotic plaque progression to complete thrombosis
Atherosclerosis (smoking, hyperlipidemia); may have chronic ischemia history
Venous thrombosis
Mesenteric vein thrombosis
Portal or SMV thrombosis
Hypercoagulable states, portal hypertension, pancreatitis, malignancy
Non-occlusive (vasoconstriction)
Splanchnic vasoconstriction without vessel blockage
Functional ischemia from hypotension, medications
Severe shock, diuretics, vasoconstrictors, dehydration
Chronic mesenteric ischemia (LO3)
Postprandial increased blood flow demand cannot be met by stenosed mesenteric vessels → visceral ischemia during meal digestion
Postprandial abdominal pain + weight loss (food fear/malabsorption) + diarrhea
Chronic mucosal ischemia → intestinal mucosal damage (malabsorption) + food avoidance due to pain
CT angiography or MR angiography (shows stenosis/occlusion of mesenteric vessels)
Malabsorption — causes & classification (LO4)
Malabsorption = inadequate absorption due to mucosal disease, pancreatic insufficiency, or luminal problems (e.g., bile salt deficiency).
CategoryMechanismExample Conditions (2)
Mucosal disease
Epithelial damage reduces surface area and nutrient transport
Celiac disease, tropical sprue, Whipple disease
Pancreatic insufficiency
Reduced pancreatic enzyme secretion into lumen
Chronic pancreatitis, cystic fibrosis
Luminal / bile problems
Reduced bile salts or impaired micelle formation
Biliary cirrhosis, bile acid sequestrant use, ileal resection
Fat-soluble vitamin (ADEK) deficiency patterns (LO4)
Vitamin A
Night blindness, Bitot spots, squamous metaplasia (corneal xerosis)
Vitamin D
Osteomalacia (bone pain, muscle weakness), hypocalcemia, secondary hyperparathyroidism
Vitamin E
Neurologic: ataxia, neuropathy, spinocerebellar degeneration
Vitamin K
Coagulopathy (prolonged PT/INR, easy bruising, bleeding)
B12 Absorption
Terminal ileum (ileocecal region)
Intrinsic factor (from gastric parietal cells)
Bile Salt Circulation
Terminal ileum (enterohepatic circulation)
More bile salts lost in stool → steatorrhea (increased fecal fat) + diarrhea
LO 4 · LO 5
ON EXAM — Celiac serology (tTG-IgA, EMA, anti-endomysial), villous atrophy histology, HLA-DQ2/DQ8, IBD vs IBS, extraintestinal manifestations
Celiac disease — pathogenesis (LO4)
Gliadin (prolamin protein in wheat gluten)
HLA-DQ2 (~95% of patients) or HLA-DQ8 (~5%)
Tissue transglutaminase (tTG); deamidation of gliadin peptides creates epitope recognized by autoreactive T cells
Villous atrophy (flattening of villi) → reduced absorptive surface
Celiac disease — serology & histology (LO4)
TestMarkerSensitivity / SpecificityWhat It Detects
First-line serology
tTG-IgA (tissue transglutaminase IgA antibody)
~98% sensitivity, ~95% specificity
Auto-antibodies against tissue transglutaminase
Endomysial antibody
Anti-endomysial IgA (EMA)
Very specific but less sensitive than tTG
Auto-antibodies against endomysium
Gold standard biopsy
Duodenal biopsy showing villous atrophy (Marsh stage 3 or higher)
Definitive diagnosis
Histologic evidence of mucosal damage
Celiac histologic stages (Marsh classification) (LO4)
Intact villi, normal crypt-to-villous ratio
Increased intraepithelial lymphocytes, normal villous architecture
25–75% loss of villous height
Flattened villi + crypt height >1:1 to villous height (completely atrophic)
IBD overview — ulcerative colitis vs Crohn disease (LO5)
KEY: Both are chronic relapsing-remitting inflammatory bowel diseases, but location, depth, and extraintestinal manifestations differ dramatically.
FeatureUlcerative ColitisCrohn Disease
Location(s)
Colon and rectum only (may have backwash ileitis)
ANY part of GI tract from mouth to anus; commonly terminal ileum + cecum
Depth of inflammation
Mucosa and submucosa only
Transmural (full thickness)
Continuous vs patchy
Continuous (no skip lesions)
Patchy with skip lesions
Rectal involvement
ALWAYS involved (continuous from rectum proximally)
Often spared (may have isolated ileocolic disease)
Bloody diarrhea?
Yes, classically bloody (mucosal ulcers)
Less common (no mucosal ulceration typically)
IBD complications — extraintestinal manifestations (LO5)
Ocular
Anterior uveitis, posterior uveitis, episcleritis
Rheumatologic
Large joint peripheral arthritis (non-erosive) + HLA-B27 association in some
Hepatic
Primary sclerosing cholangitis (PSC) + primary biliary cholangitis (PBC)
Skin
Erythema nodosum + pyoderma gangrenosum
Vascular
Hypercoagulable state (increased pro-coagulants, endothelial activation) → DVT/PE/mesenteric thrombosis
Renal
Calcium oxalate (hyperoxaluria from fat malabsorption)
LO 5 · LO 6
ON EXAM — Crohn pathognomonic findings (fissuring ulcers, fistulas, strictures), UC cancer risk, toxic megacolon, diverticulitis imaging & complications
Crohn disease — distinctive pathologic features (LO5)
PATHOGNOMONIC: Crohn has skip lesions, fissuring ulcers, fistulas, and can affect any part of GI tract from mouth to anus. Full-thickness inflammation.
Skip lesions with patchy inflammation separated by normal mucosa
Fissuring (knife-like) ulcers penetrating into submucosa and muscularis
Intersecting linear ulcers with residual mucosa creating irregular mucosal pattern
Transmural (full-thickness) inflammation allows penetration → enteroenteric, enterovesical, enterocutaneous, rectovaginal fistulas
Fibrosis from chronic transmural inflammation → luminal narrowing; "string sign" on barium study
UC vs Crohn — complications (LO5)
ComplicationUC OnlyCrohn OnlyBoth
Toxic megacolon
YES (primarily)
Rare (transmural)
Both but more UC
Colorectal cancer risk (magnitude)
Higher (~2–4% after 10 yrs)
Lower (~0.5–1% per 10 yrs)
Both elevated
Perforation
Yes (severe inflammation)
Yes (transmural)
Both
Fistulas
No (mucosal only)
YES (pathognomonic)
Crohn only
Abdominal abscess
Rare
Common (perforating ulcers)
Both but more Crohn
Diverticular disease — pathogenesis & epidemiology (LO6)
Mucosa + submucosa only (lack muscularis propria)
Penetrate at points where blood vessels enter muscularis ("natural weak points")
Low fiber (↑colonic pressure to move hard stool) + refined carbs (dysbiosis, abnormal pressure) + reduced fluid (dehydration)
Right-sided diverticula more common (genetic differences in colonic muscle architecture)
Diverticulitis — clinical presentation & imaging (LO6)
FeatureUncomplicated DiverticulitisComplicated (Perforation/Abscess/Fistula)
Location of pain (sigmoid typical)
LLQ pain
LLQ pain + peritoneal signs
Classic imaging (CT)
Diverticula + pericolic fat stranding
Diverticula + abscess/free fluid/fistula ± free air
Associated peritoneal signs
Minimal or none
Present (if perforation/peritonitis)
Management approach
Bowel rest, clear liquids, antibiotics (outpatient if mild)
NPO, IV antibiotics, possibly abscess drainage or colectomy
Diverticulitis complications (LO6)
Fistula
Pneumaturia (air in urine) + fecaluria (feces in urine) + recurrent UTI
Uterus interposes between sigmoid colon and bladder; women more prone to colovaginal fistula if hysterectomy done
Recurrence & Management
~20% (many can be managed conservatively)
After 2–3 episodes of uncomplicated or 1 episode of complicated diverticulitis
Right-sided Diverticulitis
RLQ pain, fever, elevated WBC; can be indistinguishable at diagnosis
More common in Asian populations; rare in Western populations
LO 7 · LO 8
ON EXAM — Polyp histology & malignant potential, adenoma-carcinoma sequence, Lynch syndrome vs FAP, CRC staging (TNM), high-grade dysplasia management
Colonic polyps — classification & risk (LO7)
Polyp TypeHistologyMalignant PotentialManagement
Hyperplastic polyp
Elongated crypts with sawtooth outline; superficial only
Very low (<1%)
Not removed if <5 mm; resect if >5 mm for confirmation
Sessile serrated polyp (SSP)
Irregular crypts, sessile morphology; extends deeper than hyperplastic
Moderate to high (30–50%)
Always resect; surveillance 3–5 years
Tubular adenoma
Tubular glands with adenomatous epithelium
5–10% if <1 cm; increases with size
Resect completely; surveillance 5–10 years
Villous adenoma
Frond-like villous projections (>75% villous)
HIGHEST (~40%); cancer focus in 10–15%
Resect completely; often requires surgery if large; surveillance 3 years
Tubulovillous adenoma
Mixed tubular and villous (25–75% villous)
Intermediate (10–30%)
Resect completely; surveillance 3–5 years
Adenoma-carcinoma sequence — genetics (LO8)
The canonical multi-hit hypothesis: APC loss → KRAS activation → TP53 loss → invasive carcinoma. Takes ~10 years average.
Hit #Gene% of Adenomas with MutationFunctional Change
Hit 1 (Early)
APC (adenomatous polyposis coli)
~80%
Loss of tumor suppressor → initiates adenoma formation
Hit 2 (Intermediate)
KRAS
~40%
Activating mutation → promotes cell proliferation
Hit 3 (Late)
TP53
~50% of cancers
Loss of p53 (guardian of genome) → genomic instability + invasion
Familial CRC syndromes (LO8)
SyndromeGene(s)InheritancePolyp Burden & Cancer RiskExtraintestinal Features
Familial Adenomatous Polyposis (FAP)
APC
Autosomal dominant
Hundreds to thousands of polyps; near 100% cancer risk if untreated
Osteomas, epidermoid cysts, desmoids, fundic gland polyps, CHRPE
Lynch syndrome (HNPCC)
MLH1, MSH2, MSH6, PMS2 (mismatch repair)
Autosomal dominant
Few polyps but accelerated progression; ~70% lifetime CRC risk
Endometrial cancer (often before CRC), ovarian cancer
PTEN Hamartoma Syndrome (Cowden)
PTEN
Autosomal dominant
Hamartomatous polyps throughout GI; increased CRC risk
Macrocephaly, trichilemmomas, breast/thyroid/endometrial cancers
Peutz-Jeghers Syndrome
STK11 (LKB1)
Autosomal dominant
Hamartomatous polyps; GI cancer increased (not adenomatous)
Perioral pigmentation (dark lips/buccal), breast/pancreatic/lung cancers
Colorectal cancer — TNM staging (LO8)
T = depth of tumor penetration, N = lymph node involvement, M = distant metastases. Stage I (T1–T2 N0) has ~90% 5-yr survival; Stage IV has ~10%.
TNM ComponentDepth / Extent
T1
Invasion into submucosa (but not muscularis propria)
T2
Invasion through muscularis propria into subserosa/pericolorectal fat
T3
Invasion through entire bowel wall into pericolorectal fat (beyond visceral peritoneum)
T4a
Invasion through visceral peritoneum to reach peritoneal surface
T4b
Direct invasion of adjacent structures (bladder, prostate, small bowel)
N0, N1, N2
N0 = no regional nodes | N1 = 1–3 nodes involved | N2 = 4+ nodes involved
M0 vs M1
M0 = no distant mets | M1 = distant metastases present
CRC metastatic patterns & prognosis (LO8)
Liver (portal circulation drains to liver)
Progresses along lymphatic vessels to regional nodes; N2 worsens prognosis (~25% 5-yr survival with N2 vs ~70% with N0)
Worse prognosis; mucin-producing → worse cell differentiation
Lynch: ~15% of CRC (MLH1, MSH2, MSH6, PMS2 deficiency) | Sporadic: ~5% (usually MLH1 methylation)
LO 1–8 · USMLE Step 1 Style
8 questions — cover all 8 LOs. High-yield vignettes and pathophysiology.
Q1. A 5-year-old boy presents with painless rectal bleeding for 3 weeks. Colonoscopy is unremarkable, and the bleeding has decreased. A technetium-99m pertechnetate scan is ordered. What ectopic tissue is the scan designed to identify, and where is it located?
A. Ectopic pancreatic tissue in the ileum at Meckel's diverticulum
B. Ectopic gastric mucosa in the ileum at Meckel's diverticulum
C. Heterotopic colonic mucosa in the upper jejunum
D. Ectopic stomach wall in the antimesenteric border of ileum
E. Adenomatous polyp in the terminal ileum
B — Ectopic gastric mucosa in the ileum at Meckel's diverticulum
Meckel's diverticulum is a remnant of the vitelline duct and frequently contains ectopic gastric mucosa, which secretes acid and can ulcerate adjacent ileal mucosa → painless GI bleeding (most common complication in children). The scan uses Tc-99m pertechnetate, which localizes to gastric mucosa. Located on the antimesenteric border, typically within 2 feet of the ileocecal valve (Rule of 2's: 2%, 2 feet, 2 inches, age 2).
Q2. A 68-year-old man with cognitive impairment and severe chronic constipation presents with acute abdominal distension, vomiting, and abdominal pain localized to the left lower quadrant. Abdominal X-ray shows a massively dilated sigmoid colon with a "bird's beak" appearance at the rectosigmoid junction. What is the diagnosis, and why is this patient at particularly high risk?
A. Cecal volvulus; risk factors include chronic laxative abuse and institutionalization
B. Sigmoid volvulus; risk factors include cognitive impairment, institutionalization, and chronic constipation
C. Adhesive small bowel obstruction; previous abdominal surgery is the major risk
D. Diverticulitis with perforation; elderly age and male gender increase risk
E. Intussusception in adults; malignancy as a lead point in the elderly
B — Sigmoid volvulus; risk factors include cognitive impairment, institutionalization, and chronic constipation
Sigmoid volvulus = axial twist of the sigmoid colon, classically in institutionalized elderly with cognitive impairment and chronic constipation. The "bird's beak" is pathognomonic (twist at rectosigmoid junction). Risk: immobility, laxative abuse, neuropsychiatric conditions. Can be decompressed non-operatively with endoscopic reduction or barium enema in many cases, but surgery may be needed if blood supply is compromised (strangulation).
Q3. A 2-year-old girl presents with colicky abdominal pain, palpable abdominal mass, and "currant jelly" stools. Abdominal ultrasound demonstrates a target (doughnut) sign. Which of the following BEST describes the pathophysiology of this condition?
A. Adhesions between bowel loops cause partial luminal obstruction
B. One segment of bowel telescopes into an adjacent segment, compromising blood supply
C. A congenital diverticulum acts as a lead point, twisting the intestine
D. Increased intraluminal pressure herniates the mucosa through the muscularis
E. Bacterial infection causes villous necrosis and hemorrhagic diarrhea
B — One segment of bowel telescopes into an adjacent segment, compromising blood supply
Intussusception = invagination of proximal bowel into distal bowel (most commonly ileocolic). Classic in children 6 months–3 years (peak 1–2 yrs). Presents with colicky pain, palpable mass, and "currant jelly" (blood-stained) stools. Ultrasound target sign = cross-section of invaginated mesentery + blood vessels surrounded by bowel wall. Non-operative reduction via air enema is successful in >70% if performed early; surgery if perforation or failed reduction.
Q4. A 45-year-old man with a history of atrial fibrillation presents with acute-onset severe periumbilical pain. Physical examination reveals a soft abdomen with minimal peritoneal signs. CT angiography shows an embolus occluding the superior mesenteric artery. Which segment of bowel is at GREATEST risk, and why is the "pain out of proportion" sign clinically significant?
A. Gastric antrum; early ulceration causes severe visceral pain
B. Terminal ileum; mesenteric ischemia causes loss of absorptive capacity
C. Jejunum, ileum, and right colon; visceral afferents signal ischemia before peritoneal signs develop
D. Descending and sigmoid colon; the IMA is collateral-dependent
E. Entire small intestine; SMA supplies all segments equally and is the primary blood supply
C — Jejunum, ileum, and right colon; visceral afferents signal ischemia before peritoneal signs develop
SMA supplies jejunum, ileum, cecum, ascending colon, and proximal 2/3 of transverse colon (midgut). SMA embolism is a surgical emergency with high mortality if diagnosis is delayed. The pathognomonic clue is severe pain OUT OF PROPORTION to exam — visceral afferents detect ischemia before transmural necrosis and perforation occur, before peritoneal signs manifest. Elevated lactate, bloody diarrhea, and shock are late findings. Diagnosis: CT angiography. Treatment: immediate surgical revascularization or thrombectomy.
Q5. A 28-year-old woman presents with chronic diarrhea, weight loss, and iron-deficiency anemia. Serologic testing shows elevated tissue transglutaminase (tTG) IgA and positive endomysial antibodies. Small bowel biopsy demonstrates villous atrophy with increased intraepithelial lymphocytes and crypt hyperplasia. Which of the following HLA types is she MOST likely to carry, and what dietary component triggers this pathology?
A. HLA-B27; bacterial lipopolysaccharide
B. HLA-DQ2 or HLA-DQ8; gliadin (a wheat gluten protein)
C. HLA-DR3; gliadin and related cereal proteins
D. No specific HLA type required; IgE-mediated hypersensitivity to milk proteins
E. HLA-A2; tissue damage from molecular mimicry against commensal bacteria
B — HLA-DQ2 or HLA-DQ8; gliadin (a wheat gluten protein)
Celiac disease is an autoimmune enteropathy triggered by gluten (specifically gliadin) in genetically predisposed individuals (HLA-DQ2 ~95%, HLA-DQ8 ~5%). Gliadin peptides are deamidated by tissue transglutaminase (tTG) → recognized by autoreactive T cells → mucosal inflammation → villous atrophy. Serology: tTG-IgA (most sensitive/specific) and endomysial antibodies. Biopsy is gold standard. HLA-DQ2/DQ8 is necessary but not sufficient (~3% of population carry it; only ~3% of carriers develop disease). Dietary trigger is gluten elimination (wheat, barley, rye).
Q6. A 35-year-old man with a 10-year history of crampy abdominal pain, diarrhea, and weight loss undergoes colonoscopy. Multiple areas of inflammation are noted with intervening normal-appearing mucosa (skip lesions). Biopsy reveals transmural inflammation with granulomas. Which complication is he at GREATEST risk for developing, and how does it differ pathophysiologically from ulcerative colitis?
A. Toxic megacolon; occurs exclusively in inflammatory bowel disease with continuous inflammation
B. Colorectal cancer; both UC and Crohn carry equal cancer risk after 10 years of disease
C. Fistula and stricture formation; transmural inflammation in Crohn allows penetration to involve adjacent structures
D. Massive hemorrhage; loss of colonic vasculature is more extensive in Crohn than UC
E. Fulminant colitis; mucosa-limited disease in Crohn allows rapid progression to perforation
C — Fistula and stricture formation; transmural inflammation in Crohn allows penetration to involve adjacent structures
Crohn disease is characterized by TRANSMURAL (full-thickness) inflammation with skip lesions, fissuring ulcers, and penetrating inflammation. This leads to fistulas (to other bowel loops, skin, or bladder), strictures (from fibrosis), and abscesses — unique to Crohn. Ulcerative colitis is LIMITED TO THE MUCOSA AND SUBMUCOSA → continuous inflammation in colon only → bloody diarrhea without fistulas. Toxic megacolon and CRC risk are seen in both, but fistulization is Crohn-specific. Granulomas on biopsy are pathognomonic for Crohn (~40% of cases).
Q7. A 64-year-old man with a history of chronic constipation and diverticulosis presents with acute left lower quadrant pain, fever, and leukocytosis. CT imaging reveals diverticula with pericolic fat stranding and a small fluid collection. He is treated conservatively with bowel rest and antibiotics. At follow-up 6 months later, he reports recurrent episodes of abdominal pain and has noticed pneumaturia (air in urine). What complication has developed, and why is it more common in men?
A. Colovesical fistula; more common in men because the bladder is directly anterior to the sigmoid colon without the uterus interposing
B. Chronic diverticulitis with abscess formation; men have more extensive diverticula than women
C. Colorectal cancer arising from long-standing inflammation; older age is the predominant risk factor
D. Adhesions from recurrent inflammation causing small bowel obstruction; men have more visceral adhesions
E. Pericolic abscess with rupture into peritoneum; severe sepsis in men but not women
A — Colovesical fistula; more common in men because the bladder is directly anterior to the sigmoid colon without the uterus interposing
Diverticulitis complicated by fistulization most commonly involves colovesical fistula (sigmoid → bladder) due to anatomic proximity. Pneumaturia (air in urine) and fecaluria are pathognomonic. More common in men because women have the uterus between sigmoid and bladder, protecting against fistula formation (women more prone to colovaginal fistula if hysterectomy has been performed). Colovaginal fistula presents with feculent vaginal discharge. Other fistulas: coloenteric, colocutaneous. Fistulous diverticulitis often requires elective colectomy after acute phase resolves.
Q8. A 42-year-old woman is found to have a 1.2 cm tubular adenoma during routine colonoscopy with no other polyps noted. The adenoma is removed completely with clear margins. What is the recommended surveillance interval for the next colonoscopy, and what molecular event is she at risk of NOT having prevented through polypectomy?
A. Return in 1 year; adenomatous polyps that are not removed progress to carcinoma within 2–3 years
B. Return in 5 years; even small adenomas contain both KRAS and TP53 mutations
C. Return in 10 years; small adenomas have not yet acquired the TP53 mutation necessary for malignant transformation
D. Return in 3 years; all adenomas progress to cancer if given sufficient time (adenoma-carcinoma sequence)
E. Return in 2 years; the small size suggests aggressive biology and early acquisition of KRAS mutation
C — Return in 10 years; small adenomas have not yet acquired the TP53 mutation necessary for malignant transformation
The adenoma-carcinoma sequence is a multi-hit process: APC loss (early) → KRAS activation (intermediate) → TP53 loss (late) → invasion. Small adenomas (<1 cm) typically have NOT yet acquired the TP53 mutation, so polypectomy effectively prevents cancer development. Surveillance: 1 adenoma <1 cm → 10 years; 2–3 adenomas or 1 adenoma ≥1 cm → 5 years; ≥4 adenomas or any with high-grade dysplasia → 3 years. The process takes ~10 years average from adenoma to cancer, giving a window for screening and surveillance to prevent CRC.